Neurocytoma: Symptoms, Diagnosis, Treatment, and Prognosis

Home » Neurooncology » Neurocytoma: Symptoms, Diagnosis, Treatment, and Prognosis

Neurocytoma is a rare, low-grade (WHO Grade 2) neuronal central nervous system tumor that predominantly develops within the ventricular system or less frequently in the brain parenchyma. Requiring multimodal imaging, synaptophysin histopathological confirmation, and maximal safe microsurgical resection, prompt management provides favorable long-term disease control.

Neurocytomas represent an uncommon neuronal tumor that develops within the central nervous system, most frequently along the lateral ventricles near the foramen of Monro (central neurocytoma), and less commonly in the brain parenchyma as extraventricular neurocytoma (EVN). They belong to the broader category of primary brain tumors and glioneuronal tumors.

Most of these tumors correspond to WHO Grade 2, with a generally favorable course, but atypical neurocytomas may recur and require closer monitoring.

Pathology and Classification

1. Histopathologic Features

Composed of small, uniform neuronal cells embedded in a fine neuropil background.
Synaptophysin-positive, confirming neuronal origin.
Ki-67/MIB-1 labeling index >2–4% indicates atypical neurocytoma with higher recurrence potential.

2. WHO 2021 Classification

Central Neurocytoma (Grade 2): Intraventricular, usually benign with a favorable outcome.
Extraventricular Neurocytoma (Grade 2): Parenchymal, may show slightly more variable biological behavior.

Clinical Presentation

1. Central Neurocytoma

Symptoms arise mainly from CSF obstruction and hydrocephalus:

Positional headache
Nausea, vomiting, or papilledema
Cognitive impairment or memory issues
Seizures in some cases

2. Extraventricular Neurocytoma

Symptoms correspond to the parenchymal location of the tumor:

Seizures (especially with cortical involvement)
Focal neurological deficits such as weakness or sensory loss
Behavioral or cognitive changes

Diagnosis

Radiological Examination

MRI is the gold standard, showing a heterogeneous mass with cystic or calcified components. CT may better identify calcifications. Central neurocytoma radiology findings may mimic oligodendroglioma or ependymoma, so histopathology is mandatory.

Histopathology and Immunohistochemistry

Tissue sampling confirms the diagnosis. Synaptophysin positivity confirms neuronal lineage, while the Ki-67 proliferation index guides prognosis and identifies atypical variants.

Treatment Options

1. Microsurgical Resection

Gross total resection is the cornerstone of therapy and offers the best long-term control. Subtotal resection carries a higher risk of recurrence.

2. Radiotherapy

Reserved for residual tumors, recurrence, or atypical histology. Can be stereotactic radiosurgery or fractionated radiation therapy depending on tumor size and anatomical location.

3. Chemotherapy

Has no standard role in initial management; mainly considered for refractory or recurrent cases that fail surgery and radiation, or within clinical trials.

Frequently Asked Questions

What is a neurocytoma?

A neurocytoma is a rare, typically low-grade (WHO Grade 2) neuronal brain tumor that arises inside the ventricles (central neurocytoma) or in the brain parenchyma (extraventricular neurocytoma).

What is the difference between central and extraventricular neurocytoma?

Central neurocytoma develops within the lateral ventricles near the foramen of Monro and causes hydrocephalus, while extraventricular neurocytoma forms in the brain tissue outside the ventricles and frequently presents with seizures.

What are the key symptoms of central neurocytoma?

Symptoms stem from increased intracranial pressure due to CSF obstruction, including positional headaches, nausea, vomiting, papilledema, memory impairment, and cognitive changes.

How is neurocytoma diagnosed?

Diagnosis requires brain MRI (showing a heterogeneous, calcified/cystic intraventricular mass), supported by CT, and confirmed via histopathology showing synaptophysin positivity.

What is the main treatment for neurocytoma?

Maximal safe microsurgical resection aiming for complete removal is the primary and most effective treatment. Radiation therapy is reserved for subtotal resection, recurrence, or atypical variants.

What defines an atypical neurocytoma?

A neurocytoma is considered atypical when the Ki-67/MIB-1 proliferation index exceeds 2–4%, indicating a higher likelihood of aggressive growth and local recurrence.

Updated: September 1, 2026 | Editor: info@ilhanelmaci.com.tr ©️ 2026 Prof. Dr. İlhan Elmacı. This content may not be copied or republished without permission.